This document provides information from Dr. Avinash Chandra on COVID-19. It discusses what COVID-19 is and is not, how it spreads, symptoms, prevention strategies, and data on infection rates. Key points include that COVID-19 is caused by a novel coronavirus, spreads through respiratory droplets from infected individuals, and can be prevented through measures like hand washing, social distancing, and disinfecting surfaces. Neurological symptoms have been reported in over 1/3 of patients with severe infections.
the Pathophysiology of COVID-19 infection, it's main ways of transmission, Viral loading and shedding, symptoms in addition to it's occupational hazards and it's precautions.
the Pathophysiology of COVID-19 infection, it's main ways of transmission, Viral loading and shedding, symptoms in addition to it's occupational hazards and it's precautions.
Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...Arun Singh
This PPT is created and updated on 14 February 2020 and it is about the epidemiology of Corona Virus Disease-19, Its preventive measures were also given, useful for department of Community Medicine
The recent pandemic has set the criteria of prevention in dentistry to a new bar.To combat covid 19 hopefully this is helpful to all my fellow dentists.
Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus.
Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Older people and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness.
There are various ways to stay away from the risk of exposure. These include isolation and quarantine, Personal Protective Equipments, social distancing, sanitization, and hand hygiene.
https://www.cognibrain.com/safety-and-preventive-measures-during-the-covid-19-pandemic/
describe about SARS-2 virus
Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV).
A novel coronavirus of zoonotic origin it mean this disease are spsread by animals to humans.
Coronavirus disease (COVID-19) is a new strain that was discovered in 2019 and has not been previously identified in humans.
The first person infected in Wuhan(hubei) in China on 17 November 2019.
The outbreak was declared a Public Health Emergency of International Concern on 30 January 2020.
COVID-19 is the name given by the WHO. On 11 February 2020. for the disease caused by the novel corona virus SARS-CoV-2.
Travel – associated cases have also been reported in a few other countries.
Outbreaks in health care workers indicate human to human transmission.
In India, first patient found in kerala on 30 January 2020.
Structure of the SARS-CoV-2 spike glycoprotein reveals the architecture of the key player of viral entry into host cells and provides a blue print for vaccine design.
Diagnosis is made based on Clinical features and history of International travel or a close contact with nCOVID POSITIVELY TESTED patients.
The CDC(The Centres for Disease Control and Prevention) recommends collection of three specimen types, lower respiratory, upper respiratory, and serum (Blood) specimens for testing.
Real – time Reverse Transcription –Polymerase Chain Reaction (rRT-PCR) test is used to diagnose nCOVID-19 in respiratory serum samples from clinical specimens.
Find the latest research on a wide range of molecular and serological assays currently available or under development:
Detection of Virus and Its Components (including Molecular Diagnostics ).
Serological (including Neutralization).
People who are at high risk
Elderly – more than 60 years.
People with decreased immunity.
People with co-morbidities such as Diabetes, Hypertension, Kidney disease etc.
Infants.
PREVENTION OF CORONA VIRUS INFECTION AMONG HEALTH WORKERS & PATIENTSSANJAY SIR
This presentation is for health care workers & patients to limit the transmission of corona virus infections. it also helps educator of medical, nursing & paramedics to teach their students about control & prevention strategies. it also create awareness among HCWs & common people.
Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...Arun Singh
This PPT is created and updated on 14 February 2020 and it is about the epidemiology of Corona Virus Disease-19, Its preventive measures were also given, useful for department of Community Medicine
The recent pandemic has set the criteria of prevention in dentistry to a new bar.To combat covid 19 hopefully this is helpful to all my fellow dentists.
Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus.
Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Older people and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness.
There are various ways to stay away from the risk of exposure. These include isolation and quarantine, Personal Protective Equipments, social distancing, sanitization, and hand hygiene.
https://www.cognibrain.com/safety-and-preventive-measures-during-the-covid-19-pandemic/
describe about SARS-2 virus
Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV).
A novel coronavirus of zoonotic origin it mean this disease are spsread by animals to humans.
Coronavirus disease (COVID-19) is a new strain that was discovered in 2019 and has not been previously identified in humans.
The first person infected in Wuhan(hubei) in China on 17 November 2019.
The outbreak was declared a Public Health Emergency of International Concern on 30 January 2020.
COVID-19 is the name given by the WHO. On 11 February 2020. for the disease caused by the novel corona virus SARS-CoV-2.
Travel – associated cases have also been reported in a few other countries.
Outbreaks in health care workers indicate human to human transmission.
In India, first patient found in kerala on 30 January 2020.
Structure of the SARS-CoV-2 spike glycoprotein reveals the architecture of the key player of viral entry into host cells and provides a blue print for vaccine design.
Diagnosis is made based on Clinical features and history of International travel or a close contact with nCOVID POSITIVELY TESTED patients.
The CDC(The Centres for Disease Control and Prevention) recommends collection of three specimen types, lower respiratory, upper respiratory, and serum (Blood) specimens for testing.
Real – time Reverse Transcription –Polymerase Chain Reaction (rRT-PCR) test is used to diagnose nCOVID-19 in respiratory serum samples from clinical specimens.
Find the latest research on a wide range of molecular and serological assays currently available or under development:
Detection of Virus and Its Components (including Molecular Diagnostics ).
Serological (including Neutralization).
People who are at high risk
Elderly – more than 60 years.
People with decreased immunity.
People with co-morbidities such as Diabetes, Hypertension, Kidney disease etc.
Infants.
PREVENTION OF CORONA VIRUS INFECTION AMONG HEALTH WORKERS & PATIENTSSANJAY SIR
This presentation is for health care workers & patients to limit the transmission of corona virus infections. it also helps educator of medical, nursing & paramedics to teach their students about control & prevention strategies. it also create awareness among HCWs & common people.
Anesthesiologist’s Prospective on Self-protection, Therapy, and Managements i...asclepiuspdfs
During the beginnings of 2020, a virus has spread from China and caused a huge surge in severe acute respiratory cases globally. Due to the high contagiousness and anomalous course of severe acute respiratory syndrome coronavirus 2, caused by coronavirus disease, abbreviated as COVID-19, the World Health Organization (W.H.O) announced it as a pandemic and strict measurements were implemented to try and protect the vulnerable populations and those fighting on the frontline of this wave.[1] Scientific personnel all over the world began reviewing hundreds of articles published by scientific authors about the preexisting coronaviruses to assess the strain and pathogenesis of COVID-19 and explore possible effective therapies. At the beginning of the pandemic, the goal was clear: Support the immune system by using preexisting drugs such as antibiotics and antivirals to prevent superinfections and alleviate possible foreseen complications, in addition to the use of prophylactic vaccines in high-risk groups. Another therapy option was the use of convalescent sera, which is a passive antibody therapy used as prophylaxis.[2] In this review, we conclude the importance of adhering to the precautionary guidelines set by the W.H.O recommended for health care workers and the general population, as the most important factor for protection against further transmission of the virus. The extra respiratory manifestations of the virus will also be highlighted along with the therapy modalities that are already being used and the upcoming vaccines that will counteract the virus.
COVID-19 (Coronavirus Disease 2019) is an infectious disease caused by the recently found virus known as SARS-CoV-2 (or coronavirus). Before the outbreak originated in Wuhan, China on December 2019, there was no information about this virus. Case Definition (India), Symptoms, Statistics, Preventive Measures, Management
It is a group of viruses that causes respiratory problems in animals and birds. Some viruses are not so dangerous, but due to biological reasons, some family members become lethal causing even death e.g. SARS (Severe acute respiratory syndrome)
MERS (Middle-east respiratory syndrome)
It is a group of viruses that causes respiratory problems in animals and birds. Some viruses are not so dangerous, but due to biological reasons, some family members become lethal causing even death e.g. SARS (Severe acute respiratory syndrome)
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
3. COVID19:WhatitisandWhatitisnot
* Coronaviruses (and Toro viruses) are classified together based on the
crown or halo-like appearance of the envelope glycoproteins, and on
characteristic features of chemistry and replication
* The virus enters the host cell, and the uncoated genome is
transcribed and translated. The mRNAs form a unique “nested
set” sharing a common 3′ end. New virions form by budding
from host cell membranes.
* Incidence peaks in the winter, taking the form of local epidemics
lasting a few weeks or months. The same serotype may return to an
area after several years.
4. COVID19:WhatitisandWhatitisnot
A novel coronavirus, previously designated 2019-nCoV
The coronavirus subfamily is further classified into four genera: alpha, beta,
gamma, and delta coronaviruses.
The human coronaviruses (HCoVs) are in two of these genera: alpha
coronaviruses (HCoV-229E and HCoV-NL63) and beta coronaviruses
(HCoV-HKU1, HCoV-OC43, Middle East respiratory syndrome coronavirus
[MERS-CoV], and the severe acute respiratory syndrome coronavirus
[SARS-CoV]
5. COVID-19 :Then&Now
*Pneumonia of unknown etiology
*Virus had features typical of the
coronavirus family and belonged to
the ꞵcoronavirus- 2B lineage.
*January 12, 2020, the WHO
designated this fast-spreading virus
as “2019-nCoV
* Novel Coronaviral Pneumonia
and CoV-associated diseases were
referred to as “COVID-19” by
WHO on February 11, 2020
6. COVID-19:Whatweseenow &before
“SARS-CoV-2” by the Coronavirus Study Group of
the International Committee on Taxonomy of
Viruses.
On March 11 the WHO declared the situation as a
pandemic which is threatening mankind to a great
extent
As of now, SARS-CoV-2 is considered as the
seventh coronavirus that infects humans.
Virus is non transmissible
Viral particle is bigger in size
It does not travel long distance
It does not spread in summer
It is killed with hot water
Alcohol kills it
7. COVID19:Howyougetit &Howyoueliminateit
Informing the population about the health
risks posed by the coronavirus disease, as
well as what they can do to protect
themselves, is the best way to mitigate the
spread and reduce the amount of further
contagion cases
9. A person can contract COVID-19 if:
● They come in contact with another person infected with the virus
● Someone infected coughs or sneezes directly to them
● They touch any surface with little droplets from infected people’s cough or
sneezes and then touch their eyes, nose or mouth
HOWdoYOUget COVID-19?
15. What to do to help prevent
the spread of the virus
Some numbers and data
about the spread
How long the virus stays
on different surfaces
Together we can overcome
this pandemic
01.PREVENTION
03.SPREAD
02.Stays
04.TEam
16. 04 05 06
01 02 03
Keep surfaces disinfected
and also avoid sharing
personal items
If you become sick, stay in
contact with others by
phone or email
Take care of the emotional
health of your household
members, including yourself
Continue to practice
everyday preventive actions
as usual
Keep the ill person in a
separate room from others in
the household
If caring for a sick household
member, monitor your own
health too
IFSOMEONE INYOURHOMEISSICK
17. Keep at least a distance of 1
meter (3 feet) between yourself
and other people
Try not to come in contact with
the elderly, as they are the most
vulnerable to the virus
SAFEDISTANCE OLDERADULTS
SOCIALDISTANCING
ONE–two
mETERs
20. PROTECTION TIPS
Keep objects and surfaces cleanMaintain social distancing
Wash your hands frequently Don’t touch eyes, nose or mouth
21. ● Cash is not accepted (only cards)
● Contact between driver and
passenger must be kept to a
minimum
● Taxis and other vehicles for hire can
only accept one passenger per fare
(excepting underage and elderly
people)
● Cover yourself with your elbow when
coughing and use hand sanitizer
● Try not to touch anything
PUBLICTRANSPORT RULES
22. PERSONAL PROTECTIVE EQUIPMENT
01 03
02 04
Lab coat or apron
(wear it correctly)
Surgical masks and
respirators
Safety gloves (must
be worn to the wrist)
Eye or face protection
(such as glasses)
29. EMERGENCY WARNINGSIGNS
04. Difficulty or trouble
when breathing
02. Persistent pressure in
the chest
03. Confusion or inability to
wake up
01. Lips or face suddenly
turning bluish
30. SYMPTOMS
SYSTEMIC Others:
Patients with COVID-19 often have a fever, dry cough
and fatigue as the primary manifestations, and in some
patients, pharyngeal pain, abdominal pain, diarrhea
and conjunctivitis are common
NEUROLOGICAL :
It has been reported that more than 1/3 of patients
experienced various neurological symptoms
Central (dizziness, headache, impaired
consciousness, acute cerebrovascular disease, ataxia
and epilepsy)
Peripheral (taste impairment, smell impairment,
vision impairment and neuralgia) and Myopathy.
The nervous system manifestations were significantly
more common in patients with severe infection
40. Cautionsinneurologyclinic
Neurologists need to wear disposable work caps, medical protective masks, work clothes such as
scrubs,
disposable latex gloves and carry hand sanitizer that contains ethanol, hydrogen peroxide or sodium
hypochlorite.
Patients and their companions must have temperature measured in triage routinely before entering the
consulting room. To reduce cross-infection, companions should avoid entering the room. Everyone
must
Wear disposable medical masks.
For patients with neurological symptoms but also highly suspicious of COVID-19, it is recommended
that
patient go to a fever clinic first and consult a neurologist later.
After work, doctors should remove the protective gear step by step according to the decontamination
protocol.
It is forbidden to leave the contaminated area wearing personal protective equipment for the purpose
41. COVID-19 TRIALSfromtheWHODatabase
(1,303 studies)
A randomized double-blind placebo-controlled trial of
intravenous plasma-purified alpha-1 antitrypsin for severe
COVID-19 illness.
CHROLOQUINE PHOSPHATE AGAINST INFECTION BY THE
NOVEL CORONAVIRUS
Clinical Study to assess positive value of blood plasma
from donors having built immunity against the new corona
virus (SARS-CoV-2) transfused to patients suffering from
SARS-CoV-2 infection
42.
43. “IsItSafefor MetoGoto Work?”
vigilantly perform hand hygiene, avoid touching her face, and use the personal
protective equipment
No guidance on how to protect essential workers
Data on occupational risk for Covid-19 are not robust
The Centers for Disease Control and Prevention (CDC) reports that health care workers
account for at least 11% of reported SARS-CoV-2 infections
high rates of infection have been reported among workers in transit, grocery, and
corrections occupations, in which maintaining safe physical distancing is difficult
44.
45. CREDITS: This presentation template was created by Slidesgo, including icons
by Flaticon, and infographics & images by Freepik
THANKS!
Do you have any questions?
avich.nr.doc@gmail.com
+977 9801203237
@avineuroavi.ch.92